Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.

For patients with metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis, semaglutide is associated with improved liver histologic outcomes.

Rentokil has also replaced two current non-executive directors with Leanne Sheraton, former chief marketing officer at Paypal (US: PYPL) and Sam Mitchell, former CEO at Valvoline (US: VVV), to support ...

Gray, or gray market medications, are nothing new, and GLP-1s — the class of weight loss wonder drug that includes semaglutide and tirzepatide — are by no means the only drugs you can buy this way. As ...

For years, metformin has been the go-to first-line oral medication for patients newly diagnosed with type 2 diabetes. But ...

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

The FDA will decide whether to approve a once-daily, 25 mg oral formulation of semaglutide (Wegovy) by the end of 2025. If ...

Drugs made to treat diabetes and weight loss could stop or even reverse a severe liver disease, according to a new study. The ...

Wegovy, the popular weight-loss drug from Novo Nordisk, will be available through several leading telehealth providers, ...

With GLP-1 shortage officially over, patients who relied on compounded copies have only bad options to choose from ...

The FDA said pharmacies or physicians could face enforcement action if they continued to make or dispense compounded semaglutide products beyond April 22. The FDA set a May 22 deadline for facilities ...

which allowed compounding pharmacies to make generic semaglutide, the main active ingredient in the weight-loss drugs. Compounding pharmacies create custom medications through mixing varying ...